关注
Thomas Fairlie
Thomas Fairlie
在 uqconnect.edu.au 的电子邮件经过验证
标题
引用次数
引用次数
年份
Differential anti-inflammatory activity of HDAC inhibitors in human macrophages and rat arthritis
RJ Lohman, A Iyer, TJ Fairlie, A Cotterell, P Gupta, RC Reid, DA Vesey, ...
Journal of Pharmacology and Experimental Therapeutics 356 (2), 387-396, 2016
492016
Duodenal eosinophils and mast cells in functional dyspepsia: a systematic review and meta-analysis of case-control studies
A Shah, T Fairlie, G Brown, MP Jones, GD Eslick, K Duncanson, N Thapar, ...
Clinical Gastroenterology and Hepatology 20 (10), 2229-2242. e29, 2022
362022
budesonide for functional dyspepsia with duodenal eosinophilia—randomised, double‐blind, placebo‐controlled parallel‐group trial
NJ Talley, MM Walker, M Jones, S Keely, N Koloski, R Cameron, T Fairlie, ...
Alimentary Pharmacology & Therapeutics 53 (12), 1332-1333, 2021
172021
Overlap of disorders of gut–brain interaction: a systematic review and meta-analysis
T Fairlie, A Shah, NJ Talley, WD Chey, N Koloski, YY Lee, KA Gwee, ...
The Lancet Gastroenterology & Hepatology 8 (7), 646-659, 2023
162023
Type 2 and type 17 effector cells are increased in the duodenal mucosa but not peripheral blood of patients with functional dyspepsia
GL Burns, JK Bruce, K Minahan, A Mathe, T Fairlie, R Cameron, C Naudin, ...
Frontiers in immunology 13, 1051632, 2023
112023
146-duodenal mucosa-associated microbiota (MAM) and gastric emptying: veillonella in the duodenal MAM linked to slow gastric emptying
ER Shanahan, A Shah, A Do, T Fairlie, P Ghasemi, TJ Hansen, ...
Gastroenterology 154 (6), S-40, 2018
82018
Small intestinal bacterial overgrowth complicating gastrointestinal manifestations of systemic sclerosis: a systematic review and meta-analysis
A Shah, V Pakeerathan, MP Jones, PC Kashyap, K Virgo, T Fairlie, ...
Journal of Neurogastroenterology and Motility 29 (2), 132, 2023
42023
Efficacy and safety of biologics in primary sclerosing cholangitis with inflammatory bowel disease: A systematic review and meta-analysis
A Shah, MP Jones, G Callaghan, T Fairlie, X Ma, EL Culver, K Stuart, ...
Hepatology Communications 8 (1), e0347, 2024
32024
TRAV26-2 T CELL RECEPTOR EXPRESSION IS ASSOCIATED WITH MUCOSAL LYMPHOCYTE RESPONSE TO WHEAT PROTEINS IN FUNCTIONAL DYSPEPSIA PATIENTS
GL Burns, M Potter, A Mathe, J Bruce, K Minahan, JL Barnes, J Pryor, ...
Clinical and translational gastroenterology, 10.14309, 2022
22022
Tu1066: small intestinal bacterial overgrowth in systemic sclerosis: a systematic review and meta-analysis of case-control studies
A Shah, V Pakeerathan, K Virgo, T Fairlie, MP Jones, NA Koloski, ...
Gastroenterology 162 (7), S-870, 2022
12022
Mo1582 IS THERE AN ASSOCIATION BETWEEN IMPROVEMENT OF GI SYMPTOMS IN PATIENTS WITH FUNCTIONAL GASTROINTESTINAL DISORDERS AND ALTERATIONS OF CIRCULATING GUT HOMING T CELLS AND …
T Fairlie, N Bray, JJ McMaster, C Chao, A Do, G Burns, S Keely, NJ Talley, ...
Gastroenterology 158 (6), S-904-S-905, 2020
12020
The COVID‐19 pandemic as a modifier of DGBI symptom severity: A systematic review and meta‐analysis
D Kulin, A Shah, T Fairlie, RK Wong, X Fang, UC Ghoshal, PC Kashyap, ...
Neurogastroenterology & Motility, e14878, 2024
2024
Su1902 SIMETHICONE SUPPRESSES THE GROWTH OF MICROBES CULTURED FROM THE HUMAN DUODENAL MUCOSA
T Fairlie, A Shah, Y Lim, JJ Teh, LF Schooth, M Morrison, GJ Holtmann
Gastroenterology 166 (5), S-866, 2024
2024
Mo1182 SMALL INTESTINAL BACTERIAL OVERGROWTH IN INTESTINAL FAILURE: A SYSTEMATIC REVIEW AND META-ANALYSIS
T Fairlie, A Shah, N Martin, MP Jones, NA Koloski, M Morrison, ...
Gastroenterology 166 (5), S-968, 2024
2024
Tu1030 A MULTIFACETED ECOLOGICAL APPROACH TO EXPLORE LINKS BETWEEN ENVIRONMENTAL FACTORS AND THE EPIDEMIOLOGY OF DISORDERS OF GUT-BRAIN INTERACTION
T Fairlie, A Shah, NA Koloski, N Moy, RK Wong, X Fang, UC Ghoshal, ...
Gastroenterology 166 (5), S-1229, 2024
2024
Tu1166 IMPACT OF ECONOMIC AND PSYCHOSOCIAL FACTORS ON SYMPTOM SEVERITY IN PATIENTS WITH DISORDERS OF GUT-BRAIN INTERACTION DURING THE COVID-19 PANDEMIC: A SYSTEMATIC REVIEW AND …
D Kulin, A Shah, T Fairlie, RK Wong, X Fang, UC Ghoshal, P Kashyap, ...
Gastroenterology 166 (5), S-1267, 2024
2024
Mo1187 SMALL INTESTINAL BACTERIAL OVERGROWTH IN CHRONIC LIVER DISEASE: AN UPDATED SYSTEMATIC REVIEW AND META-ANALYSIS OF CASE-CONTROL STUDIES
A Shah, L Spannenburg, P Thite, T Fairlie, NA Koloski, M Morrison, ...
Gastroenterology 166 (5), S-969, 2024
2024
Unveiling The Gut-brain Connectivity And Links With The Immune System: Utilising Self-reported Symptoms Or The Response To A Standardised Nutrient Challenge
M Moniruzzaman, A Shah, T Fairlie, E Noon, M Morrison, NJ Talley, ...
Gastroenterology 166 (5 s), s483-s483, 2024
2024
Su1638 THE DUODENAL MUCOSA-ASSOCIATED MICROBIOTA OF PATIENTS WITH A DISORDER OF GUT-BRAIN INTERACTION CAN BE DIFFERENTIATED BY ROME IV CRITERIA
LF Schooth, S Kang, T Fairlie, Y Lim, JJ Teh, EC Hoedt, S Keely, A Shah, ...
Gastroenterology 166 (5), S-776, 2024
2024
707 SMALL INTESTINAL BACTERIAL OVERGROWTH AS ASSESSED BY BREATH TESTING: A PROSPECTIVE EVALUATION TO THE GOLD STANDARD ASPIRATE
TJ Hansen, A Shah, T Fairlie, NA Koloski, MP Jones, GJ Holtmann
Gastroenterology 166 (5), S-167, 2024
2024
系统目前无法执行此操作,请稍后再试。
文章 1–20